| Prevalence of mood, anxiety, and substance-abuse disorders for older Americans in the national comorbidity survey-replication AM Gum, B King-Kallimanis, R Kohn The American Journal of Geriatric Psychiatry 17 (9), 769-781, 2009 | 469 | 2009 |
| Screening and brief intervention for substance misuse among older adults: The Florida BRITE project L Schonfeld, BL King-Kallimanis, DM Duchene, RL Etheridge, JR Herrera, ... American journal of public health 100 (1), 108-114, 2010 | 207 | 2010 |
| Negative perceptions of aging predict longitudinal decline in cognitive function. DA Robertson, BL King-Kallimanis, RA Kenny Psychology and aging 31 (1), 71, 2016 | 190 | 2016 |
| A bidimensional model of acculturation for Korean American older adults Y Jang, G Kim, D Chiriboga, B King-Kallimanis Journal of aging studies 21 (3), 267-275, 2007 | 179 | 2007 |
| Epidemiology of syncope/collapse in younger and older Western patient populations RA Kenny, J Bhangu, BL King-Kallimanis Progress in cardiovascular diseases 55 (4), 357-363, 2013 | 157 | 2013 |
| Comorbidity of depressive and anxiety disorders for older Americans in the national comorbidity survey-replication B King-Kallimanis, AM Gum, R Kohn The American Journal of Geriatric Psychiatry 17 (9), 782-792, 2009 | 153 | 2009 |
| FDA approval summary: atezolizumab plus paclitaxel protein-bound for the treatment of patients with advanced or metastatic TNBC whose tumors express PD-L1 P Narayan, S Wahby, JJ Gao, L Amiri-Kordestani, A Ibrahim, E Bloomquist, ... Clinical cancer research 26 (10), 2284-2289, 2020 | 120 | 2020 |
| Development of the Brief Ageing Perceptions Questionnaire (B-APQ): a confirmatory factor analysis approach to item reduction E Sexton, BL King-Kallimanis, K Morgan, H McGee BMC geriatrics 14, 1-11, 2014 | 119 | 2014 |
| Measuring frailty using self-report and test-based health measures O Theou, BL King-Kallimanis, AM O'Halloran, K Rockwood, RA Kenny Age and ageing 44 (3), 471-477, 2015 | 109 | 2015 |
| FDA approval summary: alpelisib plus fulvestrant for patients with HR-positive, HER2-negative, PIK3CA-mutated, advanced or metastatic breast cancer P Narayan, TM Prowell, JJ Gao, LL Fernandes, E Li, X Jiang, J Qiu, J Fan, ... Clinical Cancer Research 27 (7), 1842-1849, 2021 | 105 | 2021 |
| Measurement error, reliability, and minimum detectable change in the Mini-Mental State Examination, Montreal Cognitive Assessment, and Color Trails Test among community living … J Feeney, GM Savva, C O’Regan, B King-Kallimanis, H Cronin, RA Kenny Journal of Alzheimer's Disease 53 (3), 1107-1114, 2016 | 101 | 2016 |
| Negative perceptions of aging and decline in walking speed: A self-fulfilling prophecy DA Robertson, GM Savva, BL King-Kallimanis, RA Kenny PloS one 10 (4), e0123260, 2015 | 98 | 2015 |
| Psychometric evaluation of the CASP-19 quality of life scale in an older Irish cohort E Sexton, BL King-Kallimanis, RM Conroy, A Hickey Quality of Life Research 22, 2549-2559, 2013 | 90 | 2013 |
| SPIRIT-PRO Extension explanation and elaboration: guidelines for inclusion of patient-reported outcomes in protocols of clinical trials M Calvert, M King, R Mercieca-Bebber, O Aiyegbusi, D Kyte, A Slade, ... BMJ open 11 (6), e045105, 2021 | 89 | 2021 |
| Strengths and limitations of the MoCA for assessing cognitive functioning: findings from a large representative sample of Irish older adults RF Coen, DA Robertson, RA Kenny, BL King-Kallimanis Journal of geriatric psychiatry and neurology 29 (1), 18-24, 2016 | 78 | 2016 |
| The latent factors of depression from the short forms of the CES-D are consistent, reliable and valid in community-living older adults AM O’Halloran, RA Kenny, BL King-Kallimanis European Geriatric Medicine 5 (2), 97-102, 2014 | 74 | 2014 |
| FDA approval summary: pertuzumab for adjuvant treatment of HER2-positive early breast cancer LJ Howie, NS Scher, L Amiri-Kordestani, L Zhang, BL King-Kallimanis, ... Clinical Cancer Research 25 (10), 2949-2955, 2019 | 69 | 2019 |
| Outcomes of older women with hormone receptor–positive, human epidermal growth factor receptor–negative metastatic breast cancer treated with a CDK4/6 inhibitor and an … LJ Howie, H Singh, E Bloomquist, S Wedam, L Amiri-Kordestani, S Tang, ... Journal of Clinical Oncology 37 (36), 3475-3483, 2019 | 64 | 2019 |
| FDA approval summary: Ado-trastuzumab emtansine for the adjuvant treatment of HER2-positive early breast cancer S Wedam, L Fashoyin-Aje, X Gao, E Bloomquist, S Tang, R Sridhara, ... Clinical Cancer Research 26 (16), 4180-4185, 2020 | 61 | 2020 |
| Falls, non-accidental falls and syncope in community-dwelling adults aged 50 years and older: Implications for cardiovascular assessment J Bhangu, BL King-Kallimanis, OA Donoghue, L Carroll, RA Kenny PloS one 12 (7), e0180997, 2017 | 52 | 2017 |
